Considerations To Know About Hemgenix
Quantity of eligible patients: CDEC discussed the uncertainty in the number of individuals with moderately critical to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're categorized as possessing mild or average sickness could possibly have a significant